Your session is about to expire
← Back to Search
Blood flow restriction therapy for Shoulder Dislocation
Study Summary
This trial will help researchers understand if blood flow restriction training is effective in helping people recover from shoulder stabilization surgery. The study will compare the effects of physical therapy with and without blood flow restriction training. The hypothesis is that the group receiving blood flow restriction training will have better outcomes in terms of strength, function, and pain.
- Shoulder Dislocation
- Shoulder Subluxation
- Surgery
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are currently enrolled in this research project?
"Affirmative. The clinical trial portal hosts information that this medical study, first published on June 23rd 2022 and recently modified August 15th 2022, is looking for volunteers to participate. In total 40 people are needed at one location."
What are the chief goals of this investigative research?
"This 6 month clinical trial will primarily assess participant's shoulder function via the UQYBT metric. Other metrics such as NPRS, SPADI and ROM are also used to measure secondary outcomes associated with pain rating, patient reported results and range of motion respectively."
Is it possible for me to enroll in this experiment?
"In order to satisfy the inclusion criteria and join this clinical trial, interested patients should be between 17-30 years old with shoulder pain. This experiment is currently recruiting 40 individuals."
Is enrollment open to those aged 45 and over in this experiment?
"According to the criteria outlined for this trial, prospective patients must fall between 17 and 30 years old. For people younger than 18 or older than 65 there are 50 trials available as well as 254 additional clinical studies respectively."
Is enrollment still open for this clinical trial?
"This clinical trial, which was initially opened to participants on June 23rd 2022, is actively recruiting patients as reported by clinicaltrials.gov. The study has been recently updated on August 15th 2022."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger